Inflammation in Skeletal Muscle Regeneration

  • James G. Tidball
Part of the Advances in Muscle Research book series (ADMR, volume 3)

Keywords

Migration Superoxide Adenosine Fractionation Carbon Monoxide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abe T, Ohno M, Sato T, Murakami M, Kajiki M, Kodaira R (1991) “Differentiation induction” culture of human leukemic myeloid cells stimulates high production of macrophage differentiation inducing factor. Cytotechnology 5 Suppl 2:S75–S93.Google Scholar
  2. Abood EA, Jones MM (1991) Macrophages in developing mammalian skeletal muscle: evidence for muscle fibre death as a normal developmental event. Acta Anat (Basel) 140(3):201–212.Google Scholar
  3. Alexander HR, Wong GG, Doherty GM, Venzon DZ, Fraker DL, Norton JA (1992) Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor. J Exp Med 175:1139–1142.PubMedGoogle Scholar
  4. Anderson CF, Mosser DM (2002) A novel phenotype for an activated macrophage: the type 2 activated macrophage. J Leukoc Biol 72:101–106.PubMedGoogle Scholar
  5. Banner LR, Patterson PH (1994) Major changes in the expression of the mRNAs for cholinergic differentiation factor/leukemia inhibitory factor and its receptor after injury to adult peripheral nerves and ganglia. Proc Nat Acad Sci 91:7109–7113.PubMedGoogle Scholar
  6. Banner LR, Patterson PH, Allchorne A, Poole S, Woolf CJ (1998) Leukemia inhibitory factor is an anti-inflammatory and analgesic cytokine. J Neurosci 18:5456–5462.PubMedGoogle Scholar
  7. Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, Williamson R, McNeil PL, Campbell KP (2003) Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 423:168–172.PubMedGoogle Scholar
  8. Barnard W, Bower J, Brown MA, Murphy M, Austin L (1994) Leukemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: injured muscle expresses LIF mRNA. J Neurol Sci 123:108–113.PubMedGoogle Scholar
  9. Beutler B, Greenwald D, Hulmes JD, Chang M, Pan YC, Mathison J, Ulevitch R, Cerami A (1985) Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316(6028):552–554.PubMedGoogle Scholar
  10. Bondesen BA, Mills ST, Kegley KM, Pavlath GK (2004) The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am J Physiol Cell Physiol 287:C475-C483.PubMedGoogle Scholar
  11. Bondesen BA, Mills ST, Pavlath GK (2006) COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms. Am J Physiol Cell Physiol 290(6):C1651–1659.PubMedGoogle Scholar
  12. Bower J, Vakakis N, Nicola NA, Austin L (1995) Specific binding of leukemia inhibitory factor to murine myoblasts in culture. J Cell Physiol 164:93–98.PubMedGoogle Scholar
  13. Buechler C, Ritter M, Orso E, Langmann T, Klucken J, Schmitz G (2000) Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol 67:97–103.PubMedGoogle Scholar
  14. Campbell IK, Waring P, Novak U, Hamilton JA (1993) Production of leukemia inhibitory factor by human articular chondrocytes and cartilage in response to interleukin-1 and tumor necrosis factor alpha. Arthritis Rheum 36:790–794.PubMedGoogle Scholar
  15. Cantini M, Carraro U (1995) Macrophage-released factor stimulates selectively myogenic cells in primary muscle culture. J Neuropathol Exp Neurol 54:121–128.PubMedGoogle Scholar
  16. Cantini M, Giurisato E, Radu C, Tiozzo S, Pampinella F, Senigaglia D, Zaniolo G, Mazzoleni F, Vittiello L (2002) Macrophage-secreted myogenic factors: a promising tool for greatly enhancing the prolieferative capacity of myoblasts in vitro and in vivo. Neurol Sci 23:189–194.PubMedGoogle Scholar
  17. Carlson CD, Yuchen B, Jonakait GM, Hart RP (1996) Interleukin-1β increases leukemia inhibitory factor mRNA levels through transient stimulation of transcription rate. Glia 18:141–151.PubMedGoogle Scholar
  18. Carr AC, Myzak MC, Stocker R, McCall MR, Frei B (2000) Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis. FEBS Lett 487:176–180.PubMedGoogle Scholar
  19. Chabaud M, Fossiez F, Taupin JL, Miossec P (1998) Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol 161:409–414.PubMedGoogle Scholar
  20. Chazaud B, Sonnet C, Lafuste P, Bassez G, Rimaniol A-C, Poron F, Authier F-J, Dreyfus PA, Gherardi RK (2003) Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol 163:1133–1143.PubMedGoogle Scholar
  21. Chen SE, Gerken E, Zhang Y, Zhan M, Mohan RK, Li AS, Reid MB, Li YP (2005) Role of TNF-alpha signaling in regeneration of cardiotoxin-injured muscle. Am J Physiol Cell Physiol 289(5):C1179–C1187PubMedGoogle Scholar
  22. Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, Garcia I, Browning JL (1997) TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 272(51):32401–32410.PubMedGoogle Scholar
  23. Christopher-Stine L, Plotz PH (2004) Adult inflammatory myopathies. Best Practice & Res Clin Rheum 18:331–344.Google Scholar
  24. Coletti D, Moresi V, Adamo S, Molinaro M, Sassoon D (2005) Tumor necrosis factor-α gene transfer induces cachexia and inhibits muscle regeneration. Genesis 43:120–128.PubMedGoogle Scholar
  25. Collins RA, Grounds MD (2001) The role of tumor necrosis factor alpha (TNF-alpha) in skeletal muscle regeneration. Studies in TNF-alpha (-/-) and TNF-alpha (-/-)/LT-alpha (-/-) mice. J Histochem Cytochem 49:989–1001.PubMedGoogle Scholar
  26. Contreras-Shannon V, Ochoa O, Reyes-Reyna SM, Sun D, Michalek JE, Kuziel WA, McManus LM, Shireman PK (2007) Fat accumulation with altered inflammation and regeneration in skeletal muscle of CCR2 -/- mice following ischemic injury. Am J Physiol Cell Physiol. 292(2):C953–967.PubMedGoogle Scholar
  27. David JD, Higginbotham CA (1981) Fusion of chick embryo skeletal myoblasts: interactions of prostaglandin E1, adenosine 3′:5′ monophosphate, and calcium influx. Dev Biol 82(2):308–316.PubMedGoogle Scholar
  28. Dogra C, Changotra H, Mohan S, Kumar A (2006) Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-κB and degradation of MyoD protein. J Biol Chem 281(15):10327–10336.PubMedGoogle Scholar
  29. Dowsing BJ, Morrison WA, Nicola NA, Starkey GP, Bucci T, Kilpatrick TJ (1999) Leukemia inhibitory factor is an autocrine survival factor for Schwann cells. J Neurochem 73:96–104.PubMedGoogle Scholar
  30. Entwistle A, Curtis DH, Zalin RJ (1986) Myoblast fusion is regulated by a prostanoid of the one series independently of a rise in cyclic AMP. J Cell Biol 103(3):857–866.PubMedGoogle Scholar
  31. Feng SL, Guo Y, Factor VM, Thorgeirsson SS, Bell DW, Testa JR, Peifley KA, Winkles JA (2000) The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas. Am J Pathol 156(4):1253–1261.PubMedGoogle Scholar
  32. Finkelstein DI, Bartlett PF, Horne MK, Cheema SS (1996) Leukemia inhibitory factor is a myotrophic and neurotrophic agent that enhances the reinnervation of muscle in the rat. J Neuroscience Res 46:122–128.Google Scholar
  33. Frenette J, Cai B, Tidball JG (2000) Complement activation promotes muscle inflammation during modified muscle use. Am J Pathol 156:2103–2110.PubMedGoogle Scholar
  34. Girgenrath M, Weng S, Kostek CA, Browning B, Wang M, Brown SA, Winkles JA, Michaelson JS, Allaire N, Schneider P, Scott ML, Hsu YM, Yagita H, Flavell RA, Miller JB, Burkly LC, Zheng TS (2006) TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO J 25(24):5826–5839.PubMedGoogle Scholar
  35. Godman GC (1957) On the regeneration and redifferentiation of mammalian striated muscle. J Morphol 100:27–82.Google Scholar
  36. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23–35.PubMedGoogle Scholar
  37. Gosselin LE, Barkley JE, Spencer MJ, McCormick KM, Farkas GA (2003) Ventilatory dysfunction in mdx mice: impact of tumor necrosis factor-alpha deletion. Muscle Nerve 28:336–343.PubMedGoogle Scholar
  38. Gough NM, Williams RL (1989) The pleiotropic actions of leukemia inhibitory factor. Cancer Cells 1:77–80.PubMedGoogle Scholar
  39. Grisotto PC, dos Santos AC, Coutinho-Netto J, Cherri J, Piccinato CE (2000) Indicators of oxidative injury and alterations of the cell membrane in the skeletal muscle of rats submitted to ischemia and reperfusion. J Surg Res 92:1–6.PubMedGoogle Scholar
  40. Grounds MD (1987) Phagocytosis of necrotic muscle in muscle isografts is influenced by the strain, age, and sex of host mice. J Pathol 153:71–82.PubMedGoogle Scholar
  41. Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr. (2000) NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289(5488):2363–2366.PubMedGoogle Scholar
  42. Hamilton JA, Waring PM, Filonzi EL (1993) Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-alpha. J Immunol 150:1496–1502.PubMedGoogle Scholar
  43. Hazell LJ, Stocker R (1993) Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J 290:165–172.PubMedGoogle Scholar
  44. Hilgers KF, Hartner A, Porst M, Mai M, Wittmann M, Hugo C, Ganten D, Geiger H, Veelken R, Mann JF (2000) Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury. Kidney Int 58(6):2408–2419.PubMedGoogle Scholar
  45. Hodgetts S, Radley H, Davies M, Grounds MD (2006) Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNF-alpha function with Etanercept in mdx mice. Neuromuscul Disord 16(9–10):591–602.PubMedGoogle Scholar
  46. Horsley V, Pavlath GK (2003) Prostaglandin F2(alpha) stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway. J Cell Biol 161(1):111–118.PubMedGoogle Scholar
  47. Horsley V, Jansen KM, Mills ST, Pavlath GK (2003) IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113:422–423.Google Scholar
  48. Krippendorf BB, Riley DA (1993) Distinguishing unloading- versus reloading-induced changes in rat soleus muscle. Muscle Nerve 16:99–108.PubMedGoogle Scholar
  49. Kumar AG, Ballantyne CM, Michael LH, Kukielka GL, Youker KA, Lindsey ML, Hawkins HK, Birdsall HH, MacKay CR, LaRosa GJ, Rossen RD, Smith CW, Entman ML (1997) Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation 95(3):693–700.PubMedGoogle Scholar
  50. Janardhan KS, Sandhu SK, Singh B (2006) Neutrophil depletion inhibits early and late monocyte/macrophage increase in lung inflammation. Front Biosci 11:1569–1576.PubMedGoogle Scholar
  51. Jakubowski A, Ambrose C, Parr M, Lincecum JM, Wang MZ, Zheng TS, Browning B, Michaelson JS, Baetscher M, Wang B, Bissell DM, Burkly LC (2005) TWEAK induces liver progenitor cell proliferation. J Clin Invest 115(9):2330–2340.PubMedGoogle Scholar
  52. Jansen KM, Pavlath GK (2006) Mannose receptor regulates myoblast motility and muscle growth. J Cell Biol 174(3):403–413.PubMedGoogle Scholar
  53. Jo C, Kim H, Jo I, Choi I, Jung SC, Kim J, Kim SS, Jo SA (2005) Leukemia inhibitory factor blocks early differentiation of skeletal muscle cells by activating ERK. Biochim Biophys Acta 1743(3):187–197.PubMedGoogle Scholar
  54. Kami K, Senba E (1998) Localization of leukemia inhibitory factor and interleukin-6 messenger ribonucleic acids in regenerating rat skeletal muscle. Muscle Nerve 21(6):819–822.PubMedGoogle Scholar
  55. Koh TJ, Bryer SC, Pucci AM, Sisson TH (2005) Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration. Am J Physiol Cell Physiol 289(1):C217–223.PubMedGoogle Scholar
  56. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK (2001) Identification of the haemoglobin scavenger receptor. Nature 409:198–201.PubMedGoogle Scholar
  57. Kumar AG, Ballantyne CM, Michael LH, Kukielka GL, Youker KA, Lindsey ML, Hawkins HK, Birdsall HH, MacKay CR, LaRosa GJ, Rossen RD, Smith CW, Entman ML (1997) Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation 95(3):693–700.PubMedGoogle Scholar
  58. Kurek JB, Bower JJ, Romanella M, Koentgen F, Murphy M, Austin L (1997) The role of leukemia inhibitory factor in skeletal muscle regeneration. Muscle Nerve 20:815–822.PubMedGoogle Scholar
  59. Kurek JB, S Nouri S, Kannourakis G, Murphy M, Austin L (1996) Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle. Muscle Nerve 19:1291–1301.PubMedGoogle Scholar
  60. Kurushima H, Ramprasad M, Kondratenko N, Foster DM, Quehenberger O, Steinberg D (2000) Surface expression and rapid internalization of macrosialin (mouse CD68) on elicited mouse peritoneal macrophages. J Leukoc Biol 67:104–108.PubMedGoogle Scholar
  61. Lafreniere JF, Mills P, Bouchentouf M, Tremblay JP (2006) Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo. Exp Cell Res 312(7):1127–1141.PubMedGoogle Scholar
  62. Lang R, D Patel D, Morris JJ, Rutschmanand RL, Murray PJ (2002) Shaping gene expression in activated and resting primary macrophages by IL-10. J Immunol 169:2253–2263.PubMedGoogle Scholar
  63. Langen RC, Schols AM, Kelders MC, Wouters EF, Janssen-Heininger YM (2001) Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-κB. FASEB J 15(7):1169–1180.PubMedGoogle Scholar
  64. Langen RC, Van der Velden JL, Schols AM, Kelders MC, Wouters EF, Janssen-Heininger YM (2004) Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB J 18:227–237.PubMedGoogle Scholar
  65. Langen RC, Schols AM, Kelders MC, van der Velden JL, Wouters EF, Janssen-Heininger YM (2006) Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation. Am J Respir Cell Mol Biol 35(6):689–696.PubMedGoogle Scholar
  66. Lescaudron L, Peltekian E, Fontaine-Perus J, Paulin D, Zampieri M, Garcia L, Parrish E (1999) Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant. Neuromusc Disorders 9:72–80.PubMedGoogle Scholar
  67. Li YP (2003) TNF-alpha is a mitogen in skeletal muscle. Am J Physiol Cell Physiol 285(2):C370–C376.PubMedGoogle Scholar
  68. Li Y-P, Schwartz RJ, Waddell ID, Holloway BR, Reid MB (1998) Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-κB activation in response to tumor necrosis factor α. FASEB J 12:871–880.PubMedGoogle Scholar
  69. Lieber RL, Schmitz MC, Mishra DK, Friden J (1994) Contractile and cellular remodeling in rabbit skeletal muscle after cyclic eccentric contractions. J Appl Physiol 77(4):1926–1934.PubMedGoogle Scholar
  70. Lim SK, H. Kim H, Lim SK, bin Ali A, Lim YK, Wang Y, Chong SM, Costantini F, Baumman H (1998) Increased susceptibility in Hp knockout mice during acute hemolysis. Blood92:1870–1877.PubMedGoogle Scholar
  71. Linder E, Lehto VP, Stenman S (1979) Activation of complement by cytoskeletal intermediate filaments. Nature 278:176–178.PubMedGoogle Scholar
  72. Lluis F, Roma J, Suelves M, Parra M, Aniorte G, Gallardo E, Illa I, Rodriguez L, Hughes SM, Carmeliet P, Roig M, Muñoz-Canoves P (2001) Urokinase-dependent plasminogen acivaton is required for efficient skeletal muscle regeneration in vivo. Blood 97:1703–1711.PubMedGoogle Scholar
  73. Marsters SA, Sheridan JP, Pitti RM, Brush J, Goddard A, Ashkenazi A (1998) Identification of a ligand for the death-domain-containing receptor Apo3. Curr Biol 8(9):525–528PubMedGoogle Scholar
  74. Massimino M, Rapizzi E, Cantini M, Libera L, Mazzoeni F, Arsian P, Carraro U (1997) ED2+ macrophages increase selectively myoblast proliferation in muscle cultures. Biochem Biophys Res Commun 235:754–759.PubMedGoogle Scholar
  75. Merly F, Lescaudron L, Rouaud T, Crossin F, Gardahaut MF (1999) Macrophages enhance muscle satellite cell proliferation and delay their differentiation. Muscle Nerve 22:724–732.PubMedGoogle Scholar
  76. McLennan IS (1993) Resident macrophages (ED2- and ED3-positive) do not phagocytose degenerating rat skeletal muscle fibers. Cell Tissue Res 272:193–196.PubMedGoogle Scholar
  77. Meighan-Mantha RL, Hsu DK, Guo Y, Brown SA, Feng SL, Peifley KA, Alberts GF, Copeland NG, Gilbert DJ, Jenkins NA, Richards CM, Winkles JA (1999) The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J Biol Chem 274(46):33166–33176.PubMedGoogle Scholar
  78. Metcalf D, Nicola NA, Gearing DP (1990) Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice. Blood 76:50–56.PubMedGoogle Scholar
  79. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM (2000) M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164 :6166–6173.PubMedGoogle Scholar
  80. Mishra DK, Friden J, Schmitz MC, Lieber RL (1995) Anti-inflammatory medication after muscle injury. A treatment resulting in short-term improvement but subsequent loss of muscle function. J Bone Joint Surg 77(10):1510–1519.PubMedGoogle Scholar
  81. Moestrup SK, Moller HJ (2004) CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med 36:347–354.PubMedGoogle Scholar
  82. Mosser DM (2003) The many faces of macrophage activation. J Leukoc Biol 73:209–212.PubMedGoogle Scholar
  83. Nakashima J, Tachibana M, Ueno M, Baba S, Tazaki H (1995) Tumor necrosis factor and coagulopathy in patients with prostate cancer. Cancer Res 55(21):4881–4885.PubMedGoogle Scholar
  84. Nguyen HX, Tidball JG (2003) Null mutation of gp91phox reduces muscle membrane lysis during muscle inflammation in mice. J Physiol (Lond) 553:833–841.Google Scholar
  85. Nguyen HX, Lusis AJ, JG Tidball (2005) Null mutation of myeloperoxidase in mice prevents mechanical activation of neutrophil lysis of muscle cell membranes in vitro and in vivo. J Physiol (Lond) 565:403–413.Google Scholar
  86. Nishikawa A, Murata E, Akita M, Kaneko K, Moriya O, Tomita M, Hayashi H (1998) Roles of macrophages in programmed cell death and remodeling of tail and body muscle of Xenopus laevis during metamorphosis. Histochem Cell Biol 109(1):11–17.PubMedGoogle Scholar
  87. Nishikawa K, Arai H, Inoue K (1990) Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages. J Biol Chem 265:5226–5231.PubMedGoogle Scholar
  88. Ottnad E, Parthasarathy S, Sambrano GR, Ramprasad MP, Quehenberger O, Kondratenko N, Green S, Steinberg D (1995) A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: partial purification and role in recognition of oxidatively damaged cells. Proc Natl Acad Sci U S A 92:1391–1395.PubMedGoogle Scholar
  89. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, Choi AM (2000) Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6:422–428.PubMedGoogle Scholar
  90. Otterbein LE, Choi AM (2000) Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 279:L1029–L1037.PubMedGoogle Scholar
  91. Pan J, Fukuda K, Saito M, Matsuzaki J, Kodama H, Sano M, Takahashi T, Kato T, Ogawa S (1999) Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res 84:1127–1136.PubMedGoogle Scholar
  92. Philippidis P, Mason JC, Evans BJ, Nadra I, Taylor KM, Haskard DO, Landis RC (2004) Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res 94:119–126.PubMedGoogle Scholar
  93. Podrez EA, Febbraio M, Sheibani N, Schmitt D, Silverstein RL, DP Hajjar DP, Cohen PA, Frazier WA, Hoff HF, Hazen SL (2000) Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J Clin Invest 105:1095–1108.PubMedGoogle Scholar
  94. Polek TC, Talpaz M, Darnay BG, Spivak-Kroizman T (2003) TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor. J Biol Chem 278(34):32317–32323.PubMedGoogle Scholar
  95. Rabinowitz SS, Gordon S (1991) Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli. J Exp Med 174(4):827–836.PubMedGoogle Scholar
  96. Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D (1995) The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci U S A 92:9580–9584.PubMedGoogle Scholar
  97. Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D (1996) Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci U S A 93:14833–14838.PubMedGoogle Scholar
  98. Reyes-Reyna SM, Krolick KA (2000) Chemokine production by rat myocytes exposed to interferon-gamma. Clin Immunol 94(2):105–113.PubMedGoogle Scholar
  99. Robertson TA, Maley MA, Grounds MD, Papadimitriou JM (1993) The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis. Exp Cell Res 207:321–331.PubMedGoogle Scholar
  100. Sadrzadeh SM, Graf E, Panter SS, Hallaway PE, Eaton JW (1984) Hemoglobin. A biologic Fenton reagent. J Biol Chem 259:14354–14356.PubMedGoogle Scholar
  101. Sakuma K, Nishikawa J, Nakao R, Watanabe K, Totsuka T, Nakano H, Sano M, Yasuhara M (2003) Calcineurin is a potent regulator for skeletal muscle regeneration by association with NFATc1 and GATA-2. Acta Neuropathol (Berl) 105(3):271–280.Google Scholar
  102. Schaer DJ, Boretti FS, Hongegger A, Poehler D, Linnscheid P, Staege H, Muller C, Schoedon G, Schaffner A (2001) Molecular cloning and characterization of the mouse CD163 homologue, a highly glucocorticoid-inducible member of the scavenger receptor cysteine-rich family. Immunogenetics 53:170–177.PubMedGoogle Scholar
  103. Schaer DJ (2002) The macrophage hemoglobin scavenger receptor (CD163) as a genetically determined disease modifying pathway in atherosclerosis. Atherosclerosis 163:199–201.PubMedGoogle Scholar
  104. Schaer DJ, Boretti FS, Schoedon G, Schaffner A (2002) Induction of the CD163-dependent haemoglobin uptake by macrophages as a novel anti-inflammatory action of glucocorticoids. Br J Haematol 119:239–243.PubMedGoogle Scholar
  105. Schutzle UB, Wakelam MJ, Pette D (1984) Prostaglandins and cyclic AMP stimulate creatine kinase synthesis but not fusion in cultured embryonic chick muscle cells. Biochim Biophys Acta 805(2):204–210.PubMedGoogle Scholar
  106. Shireman PK, Contreras-Shannon V, Reyes-Reyna SM, Robinson SC, McManus LM (2006) MCP-1 parallels inflammatory and regenerative responses in ischemic muscle. J Surg Res 134(1):145–157.PubMedGoogle Scholar
  107. Shireman PK, Contreras-Shannon V, Ochoa O, Karia BP, Michalek JE, McManus LM (2007) MCP-1 deficiency causes altered inflammation with impaired skeletal muscle regeneration. J Leukoc Biol 81(3):775–785.PubMedGoogle Scholar
  108. Smith LL, Anwar A, Fragen M, Rananto C, Johnson R, Holbert D (2000) Cytokines and cell adhesion molecules associated with high-intensity eccentric exercise. Eur J Appl Physiol 82(1–2):61–67.PubMedGoogle Scholar
  109. Spangenburg EE, Booth FW (2002) Multiple signaling pathways mediate LIF-induced skeletal muscle satellite cell proliferation. Am J Physiol Cell Physiol 283(1):C204–C211.PubMedGoogle Scholar
  110. Spencer MJ, Walsh CM, Dorshkind KA, Rodriguez EM, Tidball JG (1997) Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. J Clin Invest 99(11):2745–2751.PubMedGoogle Scholar
  111. Spencer MJ, Marino MW, Winkler WM (2000) Altered pathological progression of diaphragm and quadriceps in TNF-deficient and dystrophin-deficient mice. Neuromusc Disorders 10:612–619.PubMedGoogle Scholar
  112. Stark VK, Hoch JR, Warner TF, Hullett DA (1997) Monocyte chemotactic protein-1 expression is associated with the development of vein graft intimal hyperplasia. Arterioscler Thromb Vasc Biol 17(8):1614–1621.PubMedGoogle Scholar
  113. St. Pierre BA, Tidball JG (1994) Differential response of macrophage subpopulations to soleus muscle reloading following rat hindlimb suspension. J Appl Physiol 77:290–297.Google Scholar
  114. Suelves M, Lopez-Alemany R, Lluis F, Aniorte G, Serrano E, Parra M, Carmeliet P, Munoz-Canoves P (2002) Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo. Blood 99(8):2835–2844.PubMedGoogle Scholar
  115. Sulahian TH, Hogger P. Wahner AE, Wardwell K, Goulding NJ, Sorg C, Droste A, Stehling M, Wallace PK, Morganelli PM, Guyre PM (2000) Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 12:1312–1321.PubMedGoogle Scholar
  116. Summan M, McKinstry M, Warren GL, Hulderman T, Mishra D, Brumbaugh K, Luster MI, Simeonova PP (2003) Inflammatory mediators and skeletal muscle injury: a DNA microarray analysis. J Interferon Cytokine Res 23(5):237–245.PubMedGoogle Scholar
  117. Summan M, Warren GL, Mercer RR, Chapman R, Hulderman T, Van Rooijen N, Simeonova PP (2006) Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study. Am J Physiol Regul Integr Comp Physiol 290(6):R1488–R1495.PubMedGoogle Scholar
  118. Teixeira CFP, Zamuner SR, Zuliani JP, Fernandes CM, Cruz-Hofling MA, Fernandes I, Chaves F, Gutierrez JM (2003) Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Bothrops asper snake venom. Muscle Nerve 28:449–459.PubMedGoogle Scholar
  119. Thomason DB, Booth FW (1990) Atrophy of the soleus muscle by hindlimb unweighting. J Appl Physiol 68:1–12.PubMedGoogle Scholar
  120. Tidball J, Wehling-Henricks M (2007) Macrophages promote muscle membrane repair and muscle fiber growth and regeneration during modified muscle loading in mice in vivo. J Physiol (Lond) 578:327–336.Google Scholar
  121. Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A, Lowry SF (1988) Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 167(3):1211–1227.PubMedGoogle Scholar
  122. Vakakis N, Bower J, Austin L (1995) In vitro myoblast to myotube transformations in the presence of leukemia inhibitory factor. Neurochem Int 27:329–335.PubMedGoogle Scholar
  123. Verfaillie C, McGlave P (1991) Leukemia Inhibitory Factor/human interleukin for DA cells: a growth factor that stimulates the in vitro development of multipotential human hematopoietic progenitors. Blood 77:263–270.PubMedGoogle Scholar
  124. Van Velzen AG, Da Silva RP, Gordon S, Van Berkel TJ (1997) Characterization of a receptor for oxidized low-density lipoproteins on rat Kupffer cells: similarity to macrosialin. Biochem J 322:411–415.PubMedGoogle Scholar
  125. Villiger PM, Geng Y, Lotz M (1993) Induction of cytokine expression by leukemia inhibitory factor. J Clin Invest 91:1575–1581.PubMedGoogle Scholar
  126. Warren GL, Hulderman T, Jensen N, McKinstry M, Mishra M, Luster MI, Simeonova PP (2002) Physiological role of tumor necrosis factor α in traumatic muscle injury. FASEB J 16:1630–1632.PubMedGoogle Scholar
  127. Warren GL, O’Farrell L, Summan M, Hulderman T, Mishra D, Luster MI, Kuziel WA, Simeonova PP (2004) Role of CC chemokines in skeletal muscle functional restoration after injury. Am J Physiol Cell Physiol 286:C1031–C1036.PubMedGoogle Scholar
  128. Weber MA, Schnyder-Candrian S, Schnyder B, Quesniaux V, Poli V, Stewart CL, Ryffel B (2005) Endogenous leukemia inhibitory factor attenuates endotoxin response. Lab Invest 85:276–284.PubMedGoogle Scholar
  129. Wehling M, Spencer MJ, Tidball JG (2001) A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 155:123–131.PubMedGoogle Scholar
  130. Wiedow O, Meyer-Hoffert U (2005) Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. J Intern Med 257(4):319–328.PubMedGoogle Scholar
  131. Zacks SI, Sheff MF (1982) Age-related impeded regeneration of mouse minced anterior tibial muscle. Muscle Nerve 5:152–161.PubMedGoogle Scholar
  132. Zalin RJ (1987) The role of hormones and prostanoids in the in vitro proliferation and differentiation of human myoblasts. Exp Cell Res 172(2):265–281.PubMedGoogle Scholar
  133. Zhu M, Oishi K, Lee SC, Patterson PH (2001) Studies using leukemia inhibitory factor (LIF) knockout mice and a LIF adenoviral vector demonstrate a key anti-inflammatory role for this cytokine in cutaneous inflammation. J Immunol 166:2049–2054.PubMedGoogle Scholar
  134. Zouaoui Boudjeltia K, Moguilevsky N, Legssyer I, Babar S, Guillaume M, Delree P, Vanhaeverbeek M, Brohee D, Ducobu J, Remacle C (2004) Oxidation of low density lipoproteins by myeloperoxidase at the surface of endothelial cells: an additional mechanism to subendothelium oxidation. Biochem Biophys Res Commun 3252:434–438.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • James G. Tidball
    • 1
  1. 1.Departments of Physiological Science and Pathology and Laboratory MedicineUniversity of California Los AngelesLos Angeles

Personalised recommendations